Individualized portal pressure gradient threshold based on liver function categories in preventing rebleeding after TIPS

Hepatol Int. 2023 Aug;17(4):967-978. doi: 10.1007/s12072-023-10489-x. Epub 2023 Feb 17.

Abstract

Background: The evidence in Portal pressure gradient (PPG) < 12 mmHg after transjugular intrahepatic portosystemic shunt (TIPS) for preventing rebleeding mostly comes from observations in uncovered stents era. Moreover, association between Child-Pugh classes and post-TIPS hepatic encephalopathy (HE) has indicated that tolerance of PPG reduction depends on liver function. This study aimed to investigate the optimal PPG for covered TIPS and explore the optimal threshold tailored to the Child-Pugh classes to find individualized PPG to balance rebleeding and overt HE.

Methods: This multicenter retrospective study analyzed rebleeding, OHE, and mortality of patients associated with post-TIPS PPGs (8, 10, 12, and 14 mmHg) in the entire cohort and among different Child-Pugh classes. Propensity score matching (PSM) and competing risk analyses were performed for sensitivity analyses.

Results: We included 2100 consecutively screened patients undergoing TIPS. In all patients, PPG < 12 mmHg reduced rebleeding after TIPS (p = 0.022). In Child-Pugh class A, none of the PPG thresholds were discriminative of clinical outcomes. In Child-Pugh class B, 12 mmHg (p = 0.022) and 14 mmHg (p = 0.037) discriminated rebleeding, but 12 mmHg showed a higher net benefit. In Child-Pugh class C, PPG < 14 mmHg had a lower rebleeding incidence (p = 0.017), and exhibited more net benefit than 12 mmHg.

Conclusion: Different PPG standards may be required for patients with different liver function categories. A PPG threshold < 12 mmHg might be suitable for patients in Child-Pugh class B, while < 14 mmHg might be optimal for patients in Child-Pugh class C.

Keywords: Child–Pugh class; Covered stent; Decompensated liver cirrhosis; Hepatic encephalopathy; Individualized therapy; Mortality; Portal hypertension; Portal pressure gradient; Transjugular intrahepatic portosystemic shunt; Variceal rebleeding.

Publication types

  • Multicenter Study

MeSH terms

  • Esophageal and Gastric Varices* / complications
  • Gastrointestinal Hemorrhage / etiology
  • Gastrointestinal Hemorrhage / prevention & control
  • Hepatic Encephalopathy* / complications
  • Hepatic Encephalopathy* / prevention & control
  • Humans
  • Liver Cirrhosis / complications
  • Portal Pressure
  • Portasystemic Shunt, Transjugular Intrahepatic* / adverse effects
  • Retrospective Studies
  • Treatment Outcome